New: Biosimilars strategies introduced.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
July 19, 2019 - Allergan and Amgen announced the launch of Mvasi (bevacizumab-awwb), a biosimilar to Genentech’s Avastin (bevacizumab).
Download PDF
Return to publications
